Fundraising Fox
/Companies
Sign in

Scentian Bio

Founded 2021 · 18 employees on LinkedIn · 12 known investors

Find your way into Scentian Bio

Sign up to see every warm intro you have to Scentian Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Scentian Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

Scentian Bio was founded in 2021 by Andrew Králíček.

AKAndrew Králíček
Andrew KrálíčekFounder & Chief Technology OfficerAndrew Králíček is a molecular biologist and Founder & Chief Technology Officer of Scentian Bio, which develops biosensors using synthetic insect odorant receptors for chemical detection. He previously led government-funded research programs in insect olfaction that contributed to the company's founding in 2021.
JGJonathan Good
Jonathan GoodChief Executive OfficerChief Executive Officer of Scentian Bio, a biosensor company spun out of Plant & Food Research. Good has held executive positions across technology, marketing, and operations.
CCColm Carraher
Colm CarraherChief Scientific OfficerHe has conducted research on insect olfaction mechanisms, odorant receptors, and protein structure-function relationships, with expertise in cell-based assays for characterizing odorant receptor ligands and their binding specificity.
NLNikki Lorigan
Nikki LoriganChief Financial Officer

Investors · 12

DYDX Capitallisted by DYDX CapitalRedwood City

How we know: DYDX Capital's portfolio page · nzherald.co.nz · Not right? Tell us

Sproutlisted by SproutPalmerston North
Finistere VenturesreportedSan Diego

How we know: funding news · agfundernews.com · Not right? Tell us

Icehouse VenturesreportedAuckland · $120K – $2.4M

How we know: funding news · pulse2.com · Not right? Tell us

OurCrowdreportedJerusalem

How we know: funding news · Not right? Tell us

Toyota VenturesreportedLos Altos

How we know: a partner's Signal profile · funding news · agfundernews.com · the VCSheet dataset · Not right? Tell us

Also in the syndicate · 5

BoosterCultivate VenturesNew Zealand Growth Capital PartnersNZGCPOur Crowd

Funding

SEC filings, press & company announcements

$9.1M disclosed across 2 rounds · 2023–2026

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

2 people who came through Scentian Bio went on to found or lead other companies.

Dean TilyardDirectorFounded ThefactoryJonathan GoodChief Executive OfficerFounded 1000Memories

In the news

Scentian Bio Closes $2.1M Seed Fundingfinsmes.com · Sep 2023

Frequently asked questions

What does Scentian Bio do?
Scentian Bio combines synthetic biology and AI to develop biosensors based on synthesized insect odorant receptors, creating a digital sense of smell and taste that can detect and measure the concentration of thousands of compounds. Spun out of Plant & Food Research, the company holds patents around its odorant-receptor biosensing technology.
Who founded Scentian Bio?
Scentian Bio was founded by Andrew Králíček in 2021.
Who are Scentian Bio's investors?
Scentian Bio's investors include Booster Innovation Fund, DYDX Capital, Sprout, Finistere Ventures, Icehouse Ventures, OurCrowd, Toyota Ventures.
How much funding has Scentian Bio raised?
Scentian Bio has disclosed $9.1M raised across 2 rounds.